A Prospective Randomized Trial Comparing Endoscopic Submucosal Dissection(ESD) and Surgery for Early Stage Esophageal Cancer

Not Applicable

• Conditions: esophageal cancer; Cancer - Oesophageal (gullet)

• Registration Number: ACTRN12609000771257
• Lead Sponsor: inghu Enqiang

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-09-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1.early esophageal cancer diagnosed by both gastroscopy and pathological examination.
2.lesion to be mucosal or submucosal by endoscopic ultrasound( EUS).

Exclusion Criteria

1.remote metastasis by computed tomography(CT),magnetic resonance imaging(MRI) or positron emission tomography (PET). 2.after treatment of endoscopic electrocoagulation,laser,Argon gas,microwave,endoscopic mucosal resection(EMR) or repeated biopsy in the same lesion.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival rate :1,2 , 3 years after treatment. This outcom will be assessed by health care professionals through telephones or by letters.[participants will be followed up once each year for 3 years after ESD or surgery through out the study.]

Secondary Outcome Measures

Name	Time	Method
Complication rate. This outcome will be assessed through monitoring by health care professionals .[at 1month and 1 year after treatment];Complete ressection rate assessed through monitoring by health care professionals .[at 7 days after treatment];Quality of life(QOL) assessed by questionnaires.[at 1month and 1 year after treatment];average length of stay assessed by hospital records.[at discharge (post-initial intervention).]